Edward Woo
Stock Analyst at Ascendiant Capital
(3.02)
# 1,443
Out of 4,761 analysts
126
Total ratings
38.46%
Success rate
1.89%
Average return
Main Sectors:
Stocks Rated by Edward Woo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DUOT Duos Technologies Group | Maintains: Buy | $6 → $7.5 | $6.83 | +9.81% | 4 | Dec 17, 2024 | |
| ALZN Alzamend Neuro | Maintains: Buy | $35 → $32 | $0.96 | +3,241.69% | 3 | Dec 16, 2024 | |
| SURG SurgePays | Maintains: Buy | $9 → $8.5 | $1.37 | +520.44% | 5 | Dec 16, 2024 | |
| GNSS Genasys | Maintains: Buy | $4.75 → $5.5 | $3.18 | +72.96% | 2 | Dec 16, 2024 | |
| AIM AIM ImmunoTech | Maintains: Buy | $5 → $4.5 | $0.14 | +3,153.80% | 2 | Dec 10, 2024 | |
| RNXT RenovoRx | Maintains: Buy | $8.25 → $9 | $1.03 | +773.79% | 3 | Dec 10, 2024 | |
| ATOS Atossa Therapeutics | Maintains: Buy | $6.5 → $7 | $0.80 | +780.28% | 3 | Dec 9, 2024 | |
| PSTV Plus Therapeutics | Maintains: Buy | $20 → $19 | $1.20 | +1,483.33% | 2 | Dec 9, 2024 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $7.25 → $7 | $1.46 | +379.45% | 4 | Dec 9, 2024 | |
| PAVM PAVmed | Maintains: Buy | $21 → $19 | $0.79 | +2,299.60% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.75 → $9 | $1.48 | +508.11% | 3 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.75 → $4 | $0.30 | +1,251.35% | 4 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $2.75 | $0.93 | +197.30% | 2 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $1.73 | +824.86% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $0.42 | +3,032.53% | 2 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $11 | $1.23 | +794.31% | 3 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $2.28 | +1,873.68% | 4 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.25 → $8.5 | $7.49 | +13.48% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $13 | $3.52 | +269.32% | 4 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.5 → $9 | $5.71 | +57.62% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $0.85 | $0.63 | +34.92% | 4 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $800 → $100 | $4.97 | +1,912.07% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $23 | $17.01 | +35.21% | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $52 | $32.00 | +62.50% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $25 | $7.24 | +241.70% | 3 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $33 | $1.56 | +2,015.38% | 2 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $19 | $1.92 | +889.58% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $125 | $1.53 | +8,069.93% | 3 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.10 | +900.00% | 1 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17,500 → $14,000 | $4.33 | +323,248.04% | 1 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $38 | $30.01 | +26.65% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3,700 → $3,900 | $4,990.64 | -21.85% | 2 | Dec 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $133 → $168 | $196.81 | -14.64% | 1 | Dec 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $188 → $200 | $8.02 | +2,393.77% | 1 | Dec 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $30 | $15.11 | +98.54% | 1 | Dec 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $126 → $138 | $211.65 | -34.80% | 13 | Apr 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $330 | $3.69 | +8,843.09% | 1 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $3.12 | +1,903.21% | 1 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $156 → $152 | $130.95 | +16.07% | 1 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $3.36 | +614.29% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $30 | $12.38 | +142.33% | 8 | Mar 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $5.75 | $26.42 | -78.24% | 8 | Dec 27, 2021 |
Duos Technologies Group
Dec 17, 2024
Maintains: Buy
Price Target: $6 → $7.5
Current: $6.83
Upside: +9.81%
Alzamend Neuro
Dec 16, 2024
Maintains: Buy
Price Target: $35 → $32
Current: $0.96
Upside: +3,241.69%
SurgePays
Dec 16, 2024
Maintains: Buy
Price Target: $9 → $8.5
Current: $1.37
Upside: +520.44%
Genasys
Dec 16, 2024
Maintains: Buy
Price Target: $4.75 → $5.5
Current: $3.18
Upside: +72.96%
AIM ImmunoTech
Dec 10, 2024
Maintains: Buy
Price Target: $5 → $4.5
Current: $0.14
Upside: +3,153.80%
RenovoRx
Dec 10, 2024
Maintains: Buy
Price Target: $8.25 → $9
Current: $1.03
Upside: +773.79%
Atossa Therapeutics
Dec 9, 2024
Maintains: Buy
Price Target: $6.5 → $7
Current: $0.80
Upside: +780.28%
Plus Therapeutics
Dec 9, 2024
Maintains: Buy
Price Target: $20 → $19
Current: $1.20
Upside: +1,483.33%
Lucid Diagnostics
Dec 9, 2024
Maintains: Buy
Price Target: $7.25 → $7
Current: $1.46
Upside: +379.45%
PAVmed
Dec 9, 2024
Maintains: Buy
Price Target: $21 → $19
Current: $0.79
Upside: +2,299.60%
Dec 6, 2024
Maintains: Buy
Price Target: $8.75 → $9
Current: $1.48
Upside: +508.11%
Dec 5, 2024
Maintains: Buy
Price Target: $3.75 → $4
Current: $0.30
Upside: +1,251.35%
Dec 5, 2024
Maintains: Buy
Price Target: $2.5 → $2.75
Current: $0.93
Upside: +197.30%
Dec 5, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $1.73
Upside: +824.86%
Dec 5, 2024
Maintains: Buy
Price Target: $12 → $13
Current: $0.42
Upside: +3,032.53%
Dec 4, 2024
Maintains: Buy
Price Target: $14 → $11
Current: $1.23
Upside: +794.31%
Dec 2, 2024
Maintains: Buy
Price Target: $44 → $45
Current: $2.28
Upside: +1,873.68%
Nov 13, 2024
Maintains: Buy
Price Target: $8.25 → $8.5
Current: $7.49
Upside: +13.48%
Nov 12, 2024
Maintains: Buy
Price Target: $20 → $13
Current: $3.52
Upside: +269.32%
Nov 12, 2024
Maintains: Buy
Price Target: $8.5 → $9
Current: $5.71
Upside: +57.62%
Nov 11, 2024
Maintains: Buy
Price Target: $8 → $0.85
Current: $0.63
Upside: +34.92%
Nov 11, 2024
Maintains: Buy
Price Target: $800 → $100
Current: $4.97
Upside: +1,912.07%
Nov 11, 2024
Maintains: Buy
Price Target: $18 → $23
Current: $17.01
Upside: +35.21%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $52
Current: $32.00
Upside: +62.50%
Sep 9, 2024
Maintains: Buy
Price Target: $25 → $25
Current: $7.24
Upside: +241.70%
Sep 3, 2024
Maintains: Buy
Price Target: $35 → $33
Current: $1.56
Upside: +2,015.38%
Sep 3, 2024
Maintains: Buy
Price Target: $20 → $19
Current: $1.92
Upside: +889.58%
Aug 29, 2024
Maintains: Buy
Price Target: $163 → $125
Current: $1.53
Upside: +8,069.93%
Aug 5, 2024
Initiates: Buy
Price Target: $11
Current: $1.10
Upside: +900.00%
Jun 7, 2024
Maintains: Buy
Price Target: $17,500 → $14,000
Current: $4.33
Upside: +323,248.04%
Apr 1, 2024
Maintains: Buy
Price Target: $41 → $38
Current: $30.01
Upside: +26.65%
Dec 29, 2023
Maintains: Buy
Price Target: $3,700 → $3,900
Current: $4,990.64
Upside: -21.85%
Dec 29, 2023
Maintains: Buy
Price Target: $133 → $168
Current: $196.81
Upside: -14.64%
Dec 29, 2023
Maintains: Buy
Price Target: $188 → $200
Current: $8.02
Upside: +2,393.77%
Dec 29, 2023
Maintains: Buy
Price Target: $27 → $30
Current: $15.11
Upside: +98.54%
Apr 10, 2023
Maintains: Buy
Price Target: $126 → $138
Current: $211.65
Upside: -34.80%
Jan 30, 2023
Initiates: Buy
Price Target: $330
Current: $3.69
Upside: +8,843.09%
Jan 17, 2023
Initiates: Buy
Price Target: $63
Current: $3.12
Upside: +1,903.21%
Dec 19, 2022
Maintains: Buy
Price Target: $156 → $152
Current: $130.95
Upside: +16.07%
Jun 27, 2022
Initiates: Buy
Price Target: $24
Current: $3.36
Upside: +614.29%
Mar 24, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $12.38
Upside: +142.33%
Dec 27, 2021
Maintains: Sell
Price Target: $6 → $5.75
Current: $26.42
Upside: -78.24%